A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide

References

• Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 1998;92:435–40
   Google Scholar
• Busse W, Cloutier M, Dombrowski M, et al. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment – 2004 update. J Allergy Clin Immunol 2005;115: 34–46
   Google Scholar
• Report of the Working Group on Asthma and Pregnancy. Executive summary: Management of asthma during pregnancy. J Allergy Clin Immunol 1994;93:139–62
   Web of Science ®Google Scholar
• Schatz M. Interrelationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol 1999;103:S330–6
   PubMed Web of Science ®Google Scholar
• Liu S, Wen SW, Demissie K, et al. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol 2001;184:90–6
   PubMed Web of Science ®Google Scholar
• Schatz M, Zeiger RS, Hoffman CP, et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 1995;151:1170–4
   PubMed Web of Science ®Google Scholar
• Stenius-Aarniala B, Piirilâ P, Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 1988;43:12–8
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Update on selected topics 2002. J Allergy Clin Immunol 2002;110: S141–219
   Google Scholar
• The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI). The use of newer asthma and allergy medications during pregnancy. Ann Allergy Asthma Immunol 2000;84:475–80
   PubMedGoogle Scholar
• Gluck P, Gluck J. Asthma and pregnancy. RT 2004;17:10–2
   Google Scholar
• Stenius-Aarniala BS, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax 1996;51:411–4
   Google Scholar
• Murphy VE, Gibson PG, Giles WB, et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med 2003;168:1317–23
   PubMed Web of Science ®Google Scholar
• Ellegård E, Hellgren M, Torén K, et al. The incidence of pregnancy rhinitis. Gynecol Obstet Invest 2000;49:98–101
   PubMedGoogle Scholar
• Mabry RL. Rhinitis of pregnancy. South Med J 1986;79:965–71
   PubMed Web of Science ®Google Scholar
• Blaiss MS. Management of rhinitis and asthma in pregnancy. Ann Allergy Asthma Immunol 2003;90:16–22
   PubMed Web of Science ®Google Scholar
• Lekas MD. Rhinitis during pregnancy and rhinitis medicamentosa. Otolaryngol Head Neck Surg 1992;107:845–8; discussion 9
   Google Scholar
• Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997;99:S742–9
   PubMed Web of Science ®Google Scholar
• Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209–13
   PubMed Web of Science ®Google Scholar
• Slavin RG. Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps. J Allergy Clin Immunol 1988;82:950–6
   PubMed Web of Science ®Google Scholar
• Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997;99:S773–80
   Web of Science ®Google Scholar
• Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419–25
   PubMed Web of Science ®Google Scholar
• Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyper-responsiveness in allergic rhinitis. A risk factor for asthma. Chest 1987;91:671–4
   PubMed Web of Science ®Google Scholar
• Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301–4
   PubMed Web of Science ®Google Scholar
• Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478–518
   PubMed Web of Science ®Google Scholar
• Greisner 3rd WA, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19: 185–8
   Google Scholar
• Leynaert B, Neukirch F, Demoly P, et al. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106:S201–5
   PubMed Web of Science ®Google Scholar
• Corren J, Manning BE, Thompson SF, et al. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004;113:415–9
   PubMed Web of Science ®Google Scholar
• Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol 2002;89:463–6
   PubMed Web of Science ®Google Scholar
• Demoly P, Piette V, Daures JP. Treatment of allergic rhinitis during pregnancy. Drugs 2003;63:1813–20
   Google Scholar
• U.S. Food and Drug Administration. U.S. FDA labeling and prescription drug advertising: content and format for labeling for human prescription drugs. Fed Regist 1979;44:37434–67
   Google Scholar
• Kihlström I, Lundberg C. Teratogenicity study of the new glucocorticosteroid budesonide in rabbits. Arzneimittelforschung 1987;37:43–6
   PubMed Web of Science ®Google Scholar
• Adrenocorticosteroids. In: Schardein J, editor. Chemically Induced Birth Defects. 3 edn. New York: Marcel Dekker; 2001, pp.308–13
   Google Scholar
• Reinisch JM, Simon NG, Karow WG, et al. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978;202:436–8
   PubMed Web of Science ®Google Scholar
• Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J Allergy Clin Immunol 2003;111:736–42
   PubMed Web of Science ®Google Scholar
• Källén B, Rydhstroem H, Åberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999;93:392–5
   Google Scholar
• Källén BA, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003;17:255–61
   Google Scholar
• Ericson A, Källén B. Use of drugs during pregnancy-unique Swedish registration method that can be improved. Information from the Swedish Medical Products Agency 1999;1–7
   Google Scholar
• Silverman M, Sheffer A, Wooclock A, et al. Prospective pregnancy outcome data in patients with newly diagnosed, mild persistent asthma treated with once-daily budesonide: results from the START study. Am J Respir Crit Care Med 2003; 167:A772
   Google Scholar
• Silverman M, Sheffer A, Diaz P, et al. Prospective pregnancy outcome data in patients with newly diagnosed, mild persistent asthma treated with once-daily budesonide: 5-year results from the START study. Am J Respir Crit Care Med 2004; 169:A91
   Google Scholar
• Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071–6
   PubMed Web of Science ®Google Scholar
• Namazy J, Schatz M, Long L, et al. Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth. J Allergy Clin Immunol 2004;113:427–32
   PubMed Web of Science ®Google Scholar
• Lyzell E, Goldman M, Cruz-Rivera M. Worldwide post-marketing surveillance for budesonide inhalation powder (Pulmicort Turbu-haler) pregnancy-related adverse events. Ann Allergy Asthma Immunol 2003;90:49 [Abstract]
   Google Scholar
• Schardein J. Hormones and hormone antagonists. In: Schardein J, editor. Chemically induced birth defects. 3rd edn. New York: Marcel Dekker; 2001, pp.281–357
   Google Scholar
• Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385–92
   Google Scholar
• Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999; 86:242–4
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998;58:2–5
   PubMedGoogle Scholar
• Shepard TH, Brent RL, Friedman JM, et al. Update on new developments in the study of human teratogens. Teratology 2002;65:153–61
   PubMedGoogle Scholar
• Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997;56:335–40
   PubMedGoogle Scholar
• Greenberger PA, Patterson R. Beclomethasone diproprionate for severe asthma during pregnancy. Ann Intern Med 1983;98:478–80
   PubMed Web of Science ®Google Scholar
• Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001;26:394–400
   Google Scholar
• Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997;100:301–6
   PubMed Web of Science ®Google Scholar
• Data on file, AstraZeneca Pharmaceuticals, LP. 2004
   Google Scholar
• Thorsson L, Edsbäcker S, Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994;7:1839–44
   PubMed Web of Science ®Google Scholar
• Thorsson L, Borgå O, Edsbäcker S. Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder. Br J Clin Pharmacol 1999;47:619–24
   PubMed Web of Science ®Google Scholar
• Kaiser H, Aaronson D, Dockhorn R, et al. Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler. Br J Clin Pharmacol 1999;48:309–16
   PubMed Web of Science ®Google Scholar
• Queisser-Luft A, Eggers I, Stolz G, et al. Serial examination of 20 248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am J Med Genet 1996;63: 268–76
   Google Scholar
• Ferencz C, Loffredo CA, Correa-Villaseñor A, et al. Ventricular septal defects. In: Ferencz C, Loffredo CA, Correa-Villaseñor A, Wilson P, editors. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore–Washington Infant Study 1981–1989. 5th edn. Armonk: Futura Publishing Co.; 1997, pp.123–63
   Google Scholar
• Ferencz C, Loffredo CA, Correa-Villaseñor A, et al. Atrial septal defects. In: Ferencz C, Loffredo CA, Correa-Villaseñor A, Wilson P, editors. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study 1981–1989. 5th edn. Armonk: Futura Publishing Co.; 1997, pp.267–83
   Google Scholar
• Wollins DS, Ferencz C, Boughman JA, et al. A population-based study of coarctation of the aorta: comparisons of infants with and without associated ventricular septal defect. Teratology 2001;64:229–36
   PubMedGoogle Scholar
• Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc 1988;9:545–54
   PubMedGoogle Scholar
• van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55: 116–34
   Google Scholar
• Fisher WG. Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children. Ann Allergy 1994;73:515–20
   PubMedGoogle Scholar
• Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clin Ther 2004;26:473–92
   PubMed Web of Science ®Google Scholar
• Shah SR, Miller C, Pethick N, et al. Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray. Clin Ther 2003;25:2198–214
   PubMed Web of Science ®Google Scholar